TY - JOUR
T1 - ZIF-8 nano confined protein-titanocene complex core-shell MOFs for efficient therapy of Neuroblastoma
T2 - Optimization, molecular dynamics and toxicity studies
AU - Kulkarni, Sanjay
AU - Pandey, Abhijeet
AU - Nikam, Ajinkya Nitin
AU - Nannuri, Shivanand H.
AU - George, Sajan Daniel
AU - Fayaz, Shaik Mohammad Abdul
AU - Vincent, Anita P.
AU - Mutalik, Srinivas
N1 - Funding Information:
The authors are thankful to Manipal Academy of Higher Education (MAHE), Manipal, India (for Postdoctoral Fellowship to Dr. Abhijeet Pandey and Dr. TMA Pai Doctoral Fellowship to Sanjay Kulkarni and Ajinkya N Nikam). The authors are thankful to i) Manipal College of Pharmaceutical Sciences, ii) Department of Atomic and Molecular Physics and iii) Manipal Institute of Technology, MAHE, Manipal for providing necessary facilities. The authors are also thankful to Biorender.com for providing platform to construct figures.
Publisher Copyright:
© 2021 Elsevier B.V.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/5/1
Y1 - 2021/5/1
N2 - In the present study, we have developed the core-shell metal organic framework (MOF) of zinc, wherein titanocene dichloride (TC) loaded lactoferrin (Lf) functioned as a core. The complexation of TC to Lf was studies using molecular dynamics study, Quantum mechanical model and spectroscopic investigations. Plackett-Burman design was used to screen and select the critical factors affecting the responses (size, zeta potential and PDI) while the effect of those parameter on the quality attributes (size and yield) was studied by means of a Box-Behnken design. The optimised Lf-TC nanoparticles were loaded inside the ZIF-8 framework along with an anticancer agent 5 Fluorouracil and characterized using techniques like FTIR, PXRD, Raman spectroscopy, EDX and UV-NIR spectroscopy and morphological techniques like SEM, TEM, AFM. The compatibility of the loaded ZIF-8 framework was examined by haemocompatibility studies. The potential of developed nanoplatform against Neuroblastoma was assessed using a cell line studies along with in vivo toxicity studies to ascertain its safety for after in-vivo administration in Wistar rats. Therefore, we can conclude that by employing the approach of DOE we were able to optimize the size and yield of Lf-TC NPs and further by loading inside ZIF-8 framework along with an anticancer drug like 5 fluorouracil we were able to develop a potential nanoplatform for the multimodal therapy of Neuroblastoma.
AB - In the present study, we have developed the core-shell metal organic framework (MOF) of zinc, wherein titanocene dichloride (TC) loaded lactoferrin (Lf) functioned as a core. The complexation of TC to Lf was studies using molecular dynamics study, Quantum mechanical model and spectroscopic investigations. Plackett-Burman design was used to screen and select the critical factors affecting the responses (size, zeta potential and PDI) while the effect of those parameter on the quality attributes (size and yield) was studied by means of a Box-Behnken design. The optimised Lf-TC nanoparticles were loaded inside the ZIF-8 framework along with an anticancer agent 5 Fluorouracil and characterized using techniques like FTIR, PXRD, Raman spectroscopy, EDX and UV-NIR spectroscopy and morphological techniques like SEM, TEM, AFM. The compatibility of the loaded ZIF-8 framework was examined by haemocompatibility studies. The potential of developed nanoplatform against Neuroblastoma was assessed using a cell line studies along with in vivo toxicity studies to ascertain its safety for after in-vivo administration in Wistar rats. Therefore, we can conclude that by employing the approach of DOE we were able to optimize the size and yield of Lf-TC NPs and further by loading inside ZIF-8 framework along with an anticancer drug like 5 fluorouracil we were able to develop a potential nanoplatform for the multimodal therapy of Neuroblastoma.
UR - http://www.scopus.com/inward/record.url?scp=85101911210&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85101911210&partnerID=8YFLogxK
U2 - 10.1016/j.ijbiomac.2021.02.161
DO - 10.1016/j.ijbiomac.2021.02.161
M3 - Article
C2 - 33636277
AN - SCOPUS:85101911210
SN - 0141-8130
VL - 178
SP - 444
EP - 463
JO - International Journal of Biological Macromolecules
JF - International Journal of Biological Macromolecules
ER -